|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
|
|---|---|---|---|---|---|
| Net sales (including related party sales of $29,781, $42,259, and $69,791 in fiscal years 2026, 2025, and 2024, respectively) | |||||
| Total net sales (including related party sales of $29,781, $42,259, and $69,791 in fiscal years 2026, 2025, and 2024, respectively) | |||||
| Cost of sales (including related party purchases of $725,694, $650,658, and $552,136 in fiscal years 2026, 2025, and 2024, respectively) | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Income from operations | |||||
| Other income, net | |||||
| Other income (expense), net | |||||
| Interest income | |||||
| Total other income, net | |||||
| Interest expense | |||||
| Income before income tax provision | |||||
| Income tax provision | |||||
| Share of (loss) income from equity investees, net of taxes | |||||
| Net income | |||||
| Net income per common share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted-average shares used in the calculation of net income per common share: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...
